AAPG 株価推移チャート
AAPG 財務
Ascentage Pharma Group International
$19.1
3.97%
$0.73
終値： Jul 21, 16:00:00 GMT-4
$19.1
0%
$0
アフターマーケット：Jul 21, 20:00:00 GMT-4
戻る
Ascentage Pharma Group International (AAPG) 財務
主要データ
前終値
$18.37
始値
$18.74
当日レンジ
$18.64 - $19.1
52週レンジ
$16.36 - $48.45
取引高
4.9K
平均取引高
11.4K
配当利回り
--
1株当たり利益(TTM)
-2.05
時価総額
$1.7B
Ascentage Pharma Group Internatとは何ですか？
Ascentage Pharma Group International Co., Ltd. is a clinical-stage biotechnology company. The company is headquartered in Suzhou, Jiangsu and currently employs 767 full-time employees. The company went IPO on 2019-10-28. The firm's main products include Olverembatinib (HQP1351), Lisaftoclax (APG-2575), Alrizomadlin (APG-115), Pelcitoclax (APG-1252), APG-5918, and APG-2449. The firm's products are primarily used to treat chronic myeloid leukemia (CML), acute myeloid leukemia (AML), chronic lymphocytic leukemia (CLL), acute lymphoblastic leukemia (ALL), myelodysplastic syndrome (MDS) and multiple myeloma (MM). The firm primarily conducts its businesses in domestic market.
